Overview
Compare with ASPEN INSURANCE HOLDINGS LTD, Loews Corporation or Hamilton Insurance Group, Ltd., or pick any stock.
- TickerSPNT on NYSE2
- IndustryFire, Marine & Casualty Insurance2
- HeadquartersPembroke, Bermuda2
- Incorporated inBermuda3
- Business addressPoint Building, 3 Waterloo Lane, Pembroke, Hm 083
- Filer categoryLarge accelerated filer3
- Legal formExempted Companies Limited by Shares2
- LEI549300OGXFI85N3YZZ512
- StatusActive2
- LEI statusIssued and current2
- Registered address3 Waterloo Lane, HM 08 Pembroke, Bermuda2
- Registered withRegistrar of Companies (Ministry of Economic Development), 458342
See how the biggest companies compare on our leaderboards
We have licenses to write property, casualty, and accident & health insurance and reinsurance globally, including admitted and non-admitted licensed companies in the United States, a Bermuda Class 4 company, a Lloyd’s of London (“Lloyd’s”) syndicate and managing agency, and an internationally licensed company domiciled in Sweden. We have offices in 10 countries with a total employee population of 1,099 people.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs81¢$2.6B
- Interest2¢$79.7M
- Income tax3¢$81.2M
- Profit14¢$459.6M
Out of $3.2B in revenue.6
Where each dollar of operating cash went, fiscal 2025
- Share buybacks100¢$490.8M
Out of $102.4M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.6
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net earned premium | $2.6B | $2.3B | $2.4B |
| Net investment income | $274.8M | $303.6M | $283.7M |
| Net realized and unrealized investment losses | -$2.9M | -$79.0M | -$11.0M |
| Net investment income and net realized and unrealized investment losses | $271.9M | $224.6M | $272.7M |
| Other revenues | $339.4M | $184.2M | $97.8M |
| Loss on settlement and change in fair value of liability-classified capital instruments | $0 | -$148.5M | -$59.4M |
| Total revenues | $3.2B | $2.6B | $2.7B |
| Loss and loss adjustment expenses incurred, net | $1.5B | $1.4B | $1.4B |
| Acquisition costs, net | $583.6M | $516.9M | $472.7M |
| Other underwriting expenses | $187.9M | $181.7M | $196.3M |
| Net corporate and other expenses | $257.0M | $232.1M | $258.2M |
| Intangible asset amortization | $10.9M | $11.9M | $11.1M |
| Interest expense | $79.7M | $69.6M | $64.1M |
| Foreign exchange (gains) losses | $25.2M | -$10.0M | $34.9M |
| Total expenses | $2.7B | $2.4B | $2.4B |
| Income before income tax (expense) benefit | $541.3M | $233.1M | $318.7M |
| Income tax (expense) benefit | -$81.2M | -$30.7M | $45.0M |
| Net income | $460.1M | $202.4M | $363.7M |
| Net income attributable to noncontrolling interests | -$500.0K | -$2.5M | -$8.9M |
| Net income available to SiriusPoint | $459.6M | $199.9M | $354.8M |
| Dividends on Series B preference shares | -$16.0M | -$16.0M | -$16.0M |
| Net income available to SiriusPoint common shareholders, basic | $443.6M | $183.9M | $338.8M |
| Net income available to SiriusPoint common shareholders, diluted | $443.6M | $183.9M | $338.8M |
| Basic earnings per share available to SiriusPoint common shareholders (in dollars per share) | $3.80 | $1.06 | $1.93 |
| Diluted earnings per share available to SiriusPoint common shareholders (in dollars per share) | $3.64 | $1.04 | $1.85 |
| Basic (in shares) | 116.5M shares | 166.5M shares | 163.3M shares |
| Diluted (in shares) | 121.6M shares | 169.5M shares | 169.6M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Debt securities, available for sale, at fair value, net of allowance for credit losses of $0.0 (2024 - $1.1) (cost - $5,118.3; 2024 - $5,143.8) | $5.2B | $5.1B | ||
| Debt securities, trading, at fair value (cost - $114.6; 2024 - $187.3) | $90.3M | $162.2M | ||
| Short-term investments, at fair value (cost - $28.4; 2024 - $95.3) | $28.3M | $95.8M | ||
| Other long-term investments, at fair value (cost - $421.9; 2024 - $438.2) (includes related party investments at fair value of $216.1 (2024 - $217.2) | $315.1M | $316.5M | ||
| Total investments | $5.6B | $5.7B | ||
| Cash and cash equivalents | $731.2M | $682.0M | ||
| Restricted cash and cash equivalents | $171.2M | $212.6M | ||
| Due from brokers | $7.5M | $11.2M | ||
| Interest and dividends receivable | $47.1M | $44.0M | ||
| Insurance and reinsurance balances receivable, net | $2.3B | $2.1B | ||
| Deferred acquisition costs, net | $384.1M | $327.5M | $308.9M | |
| Unearned premiums ceded | $487.4M | $463.9M | ||
| Loss and loss adjustment expenses recoverable, net | $2.1B | $2.3B | $2.3B | $1.4B |
| Deferred tax asset | $267.7M | $297.0M | ||
| Intangible assets | $121.2M | $140.8M | ||
| Other assets | $272.1M | $270.7M | ||
| Assets held for sale | $115.2M | $0 | ||
| Total assets | $12.6B | $12.5B | ||
| Loss and loss adjustment expense reserves | $5.8B | $5.7B | $5.6B | $5.3B |
| Unearned premium reserves | $1.9B | $1.6B | ||
| Reinsurance balances payable | $1.4B | $1.8B | ||
| Deferred gain on retroactive reinsurance | $0 | $8.5M | ||
| Debt | $688.6M | $639.1M | ||
| Due to brokers | $5.5M | $18.0M | ||
| Deferred tax liability | $73.0M | $76.2M | ||
| Share repurchase liability | $0 | $483.0M | ||
| Other liabilities | $246.1M | $286.6M | ||
| Total liabilities | $10.1B | $10.6B | ||
| Common shares (issued and outstanding: 116,989,799; 2024 - 116,429,057) | $11.7M | $11.6M | ||
| Additional paid-in capital | $967.7M | $945.0M | ||
| Retained earnings | $1.2B | $784.9M | ||
| Accumulated other comprehensive income (loss), net of tax | $61.9M | -$4.1M | ||
| Shareholders equity attributable to SiriusPoint shareholders | $2.5B | $1.9B | ||
| Noncontrolling interests | $1.1M | $1.4M | $16.7M | |
| Total shareholders equity | $2.5B | $1.9B | $2.5B | |
| Total liabilities, noncontrolling interests and shareholders equity | $12.6B | $12.5B | ||
| Debt securities, available for sale, allowance for credit losses | $0 | $1.1M | ||
| Debt securities, available for sale, cost | $5.1B | $5.1B | ||
| Debt securities, trading, cost | $114.6M | $187.3M | ||
| Short-term investments, cost | $28.4M | $95.3M | ||
| Other long-term investments, cost | $421.9M | $438.2M | ||
| Related party investments at fair value | $216.1M | $217.2M | ||
| Preference shares, par value (in dollars per share) | $0.10 | $0.10 | ||
| Preference shares, shares authorized (in shares) | 8.0M shares | 8.0M shares | ||
| Preference shares, shares issued (in shares) | 8.0M shares | 8.0M shares | ||
| Common shares, shares issued (in shares) | 117.0M shares | 116.4M shares | ||
| Common shares, shares outstanding (in shares) | 117.0M shares | 116.4M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Debt securities, available for sale, at fair value, net of allowance for credit losses of $0.0 (2024 - $1.1) (cost - $5,118.3; 2024 - $5,143.8) | $5.2B | $5.1B | ||
| Debt securities, trading, at fair value (cost - $114.6; 2024 - $187.3) | $90.3M | $162.2M | ||
| Short-term investments, at fair value (cost - $28.4; 2024 - $95.3) | $28.3M | $95.8M | ||
| Other long-term investments, at fair value (cost - $421.9; 2024 - $438.2) (includes related party investments at fair value of $216.1 (2024 - $217.2) | $315.1M | $316.5M | ||
| Total investments | $5.6B | $5.7B | ||
| Cash and cash equivalents | $731.2M | $682.0M | ||
| Restricted cash and cash equivalents | $171.2M | $212.6M | ||
| Due from brokers | $7.5M | $11.2M | ||
| Interest and dividends receivable | $47.1M | $44.0M | ||
| Insurance and reinsurance balances receivable, net | $2.3B | $2.1B | ||
| Deferred acquisition costs, net | $384.1M | $327.5M | $308.9M | |
| Unearned premiums ceded | $487.4M | $463.9M | ||
| Loss and loss adjustment expenses recoverable, net | $2.1B | $2.3B | $2.3B | $1.4B |
| Deferred tax asset | $267.7M | $297.0M | ||
| Intangible assets | $121.2M | $140.8M | ||
| Other assets | $272.1M | $270.7M | ||
| Assets held for sale | $115.2M | $0 | ||
| Total assets | $12.6B | $12.5B | ||
| Loss and loss adjustment expense reserves | $5.8B | $5.7B | $5.6B | $5.3B |
| Unearned premium reserves | $1.9B | $1.6B | ||
| Reinsurance balances payable | $1.4B | $1.8B | ||
| Deferred gain on retroactive reinsurance | $0 | $8.5M | ||
| Debt | $688.6M | $639.1M | ||
| Due to brokers | $5.5M | $18.0M | ||
| Deferred tax liability | $73.0M | $76.2M | ||
| Share repurchase liability | $0 | $483.0M | ||
| Other liabilities | $246.1M | $286.6M | ||
| Total liabilities | $10.1B | $10.6B | ||
| Common shares (issued and outstanding: 116,989,799; 2024 - 116,429,057) | $11.7M | $11.6M | ||
| Additional paid-in capital | $967.7M | $945.0M | ||
| Retained earnings | $1.2B | $784.9M | ||
| Accumulated other comprehensive income (loss), net of tax | $61.9M | -$4.1M | ||
| Shareholders equity attributable to SiriusPoint shareholders | $2.5B | $1.9B | ||
| Noncontrolling interests | $1.1M | $1.4M | $16.7M | |
| Total shareholders equity | $2.5B | $1.9B | $2.5B | |
| Total liabilities, noncontrolling interests and shareholders equity | $12.6B | $12.5B | ||
| Debt securities, available for sale, allowance for credit losses | $0 | $1.1M | ||
| Debt securities, available for sale, cost | $5.1B | $5.1B | ||
| Debt securities, trading, cost | $114.6M | $187.3M | ||
| Short-term investments, cost | $28.4M | $95.3M | ||
| Other long-term investments, cost | $421.9M | $438.2M | ||
| Related party investments at fair value | $216.1M | $217.2M | ||
| Preference shares, par value (in dollars per share) | $0.10 | $0.10 | ||
| Preference shares, shares authorized (in shares) | 8.0M shares | 8.0M shares | ||
| Preference shares, shares issued (in shares) | 8.0M shares | 8.0M shares | ||
| Common shares, shares issued (in shares) | 117.0M shares | 116.4M shares | ||
| Common shares, shares outstanding (in shares) | 117.0M shares | 116.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $460.1M | $202.4M | $363.7M |
| Share compensation | $35.9M | $20.7M | $21.4M |
| Net realized and unrealized loss on investments and derivatives | $2.9M | $79.0M | $6.9M |
| Change in fair value of liability-classified capital instruments | $0 | $31.9M | $59.4M |
| Gain from sale of consolidated subsidiary | -$222.4M | $0 | $0 |
| Amortization of premium and accretion of discount, net | -$34.6M | -$61.2M | -$67.1M |
| Amortization of intangible assets | $10.9M | $11.9M | $11.1M |
| Other items, net | $49.5M | -$42.4M | $23.7M |
| Insurance and reinsurance balances receivable, net | -$206.7M | -$87.9M | -$84.3M |
| Deferred acquisition costs, net | -$56.6M | -$18.6M | -$14.0M |
| Unearned premiums ceded | -$23.5M | -$14.7M | -$100.4M |
| Loss and loss adjustment expenses recoverable, net | $213.0M | -$20.2M | -$918.9M |
| Deferred tax asset/liability | $22.2M | $11.2M | -$84.4M |
| Other assets | -$25.1M | -$110.0M | -$28.8M |
| Interest and dividends receivable | -$3.1M | -$1.7M | -$15.6M |
| Loss and loss adjustment expense reserves | $128.6M | $45.8M | $339.4M |
| Unearned premium reserves | $216.2M | $11.9M | $106.2M |
| Deferred gain on retroactive reinsurance | -$8.5M | -$19.4M | $27.9M |
| Reinsurance balances payable | -$334.0M | $44.9M | $923.6M |
| Other liabilities | -$7.2M | -$8.9M | $11.5M |
| Held for sale asset | -$115.2M | $0 | $0 |
| Net cash provided by operating activities | $102.4M | $74.7M | $581.3M |
| Purchases of debt securities, available-for-sale | -$2.3B | -$2.3B | -$3.6B |
| Purchases of short-term investments | -$122.5M | -$432.9M | -$1.4B |
| Purchases of other investments | -$23.4M | -$28.6M | -$5.5M |
| Proceeds from sales and maturities of debt securities, available-for-sale | $2.4B | $1.9B | $1.5B |
| Proceeds from sales and maturities of debt securities, trading and short-term investments | $240.4M | $1.1B | $3.0B |
| Proceeds from sales and maturities of other investments | $12.5M | $64.0M | $81.7M |
| Change in due to/from brokers, net | -$8.8M | $6.2M | $5.5M |
| Proceeds from sale of consolidated subsidiary, net of cash sold | $224.9M | $0 | $0 |
| Net cash provided by investing activities | $424.2M | $343.6M | -$332.2M |
| Taxes paid on withholding shares | -$6.3M | -$9.8M | -$11.5M |
| Repayment of loans under an agreement to repurchase | $0 | $0 | -$18.0M |
| Cash dividends paid to preference shareholders | -$16.0M | -$16.0M | -$16.0M |
| Payment of redemption of debt | $0 | -$517.9M | $0 |
| Proceeds from issuance of debt, net of costs | $0 | $393.9M | $0 |
| Settlement of liability-classified capital instruments | $0 | -$99.2M | -$38.5M |
| Net proceeds from exercise of options | $900.0K | $18.4M | $27.8M |
| Net payments on deposit liability contracts | -$5.8M | -$94.4M | -$6.1M |
| Purchases of SiriusPoint common shares under share repurchase program | -$490.8M | -$299.7M | $0 |
| Change in total noncontrolling interests, net | -$800.0K | -$300.0K | $800.0K |
| Net cash used in financing activities | -$518.8M | -$625.0M | -$61.5M |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $7.8M | -$206.7M | $187.6M |
| Interest paid in cash | $78.0M | $66.4M | $46.1M |
| Income taxes paid in cash | $81.7M | $50.6M | $49.6M |
No quarter-by-quarter statement was filed.
Corporate structure
SiriusPoint Ltd sits at the top of its group. 29 entities, 9 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of SiriusPoint Ltd
- DONALD SMITH & CO., INC. Filed SCHEDULE 13G on SiriusPoint Ltd, latest Aug 11, 2026 (7 filings since Feb 14, 2025)
- Capital Research Global Investors Filed SCHEDULE 13G/A on SiriusPoint Ltd, latest May 14, 2026 (7 filings since Feb 11, 2022)
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on SiriusPoint Ltd, latest Apr 28, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on SiriusPoint Ltd, latest Mar 26, 2026 (6 filings since Feb 10, 2022)
- Wellington Management Company Filed SCHEDULE 13G/A on SiriusPoint Ltd, latest Nov 12, 2025 (6 filings since Feb 4, 2022)
- BlackRock Filed SCHEDULE 13G/A on SiriusPoint Ltd, latest Apr 23, 2025 (8 filings since Feb 3, 2022)
- DIMENSIONAL FUND ADVISORS LP Filed SCHEDULE 13G on SiriusPoint Ltd, latest Apr 15, 2025 (2 filings since Feb 8, 2022)
- CM BERMUDA Ltd Filed SCHEDULE 13D/A on SiriusPoint Ltd, latest Mar 3, 2025 (4 filings since Nov 22, 2024)
- Daniel S. Loeb Filed SCHEDULE 13D/A on SiriusPoint Ltd, latest Feb 28, 2025 (5 filings since May 17, 2022)
- SiriusPoint Ltd Pembroke, Bermuda
- Akeso Care Management, Inc. Subsidiary · Indiana, United States
- ALC Health (Hong Kong) LTD. Subsidiary · Hong Kong
- Alstead Reinsurance Ltd. Subsidiary · Bermuda
- Gate's Bay Services Limited Subsidiary · United Kingdom
- Global Response Limited Subsidiary · United Kingdom
- IMG CANADA INSURANCE SERVICES LTD. Subsidiary · Canada
- IMG Europe AB Subsidiary · Sweden
- International Medical Administrators, Inc. Subsidiary · Nebraska, United States
- International Medical Group Holdings Limited Subsidiary · United Kingdom
- International Medical Group Limited Subsidiary · United Kingdom
- iTravelInsured, Inc. Subsidiary · Indiana, United States
- Oakwood Insurance Company Subsidiary · Tennessee, United States
- S.I. Holdings (Luxembourg) S.á r.l Subsidiary · Luxembourg
- Sirius Acquisitions Holding Company Subsidiary · Delaware, United States
- Sirius Global Services LLC Subsidiary · Delaware, United States
- Sirius Group International S.á r.l Subsidiary · Luxembourg
- Sirius Insurance Holding Sweden AB Subsidiary · Sweden
- SIRIUS INTERNATIONAL CORPORATE MEMBER LIMITED Subsidiary · London, United Kingdom
- SIRIUS INTERNATIONAL HOLDINGS (NL) B.V. Subsidiary · Amsterdam, Netherlands
- Sirius International Managing Agency Limited Subsidiary · United Kingdom
- Sirius International UK Holdings II Ltd Subsidiary · United Kingdom
- Sirius Re Holdings, Inc. Subsidiary · Delaware, United States
- SiriusPoint America Insurance Company Subsidiary · New York, United States
- SiriusPoint Bermuda Insurance Company Ltd. Subsidiary · Bermuda
- SiriusPoint International Advisory Zurich LLC Subsidiary · Switzerland
- and 3 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What SiriusPoint Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Operating-lease assets (leased space) | $20.7M6 Dec 31, 2025 | $22.8M6 Dec 31, 2024 | −9.2% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $731.2M6 Dec 31, 2025 | $682.0M6 Dec 31, 2024 | +7.2% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $121.2M6 Dec 31, 2025 | $140.8M6 Dec 31, 2024 | −13.9% |
| Finite-lived intangibles, net | $73.3M6 Dec 31, 2025 | $93.0M10 Dec 31, 2024 | −21.2% |
Properties, in its own words
The Company leases office space in Pembroke, Bermuda where the Company’s principal executive office is located. Additionally, the Company leases office space throughout the United States, United Kingdom and Europe. We renew and enter into new leases in the ordinary course of business. We believe that our office space is sufficient for us to conduct our operations for the foreseeable future. For further discussion of our leasing commitments at December 31, 2025, refer to Note 21 “Commitments and contingencies” in our audited consolidated financial statements included elsewhere in this Annual Report.
Item 2 of the 10-K filed Feb 24, 2026.5
Leadership
Who has led SiriusPoint Ltd, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
201520202025
- Chief executive officerRobin Gibbs Mar 8, 2023 to now15
- Chief executive officerScott Egan Sep 22, 2022 to Mar 8, 202316
- Chief executive officerSid Sankaran Mar 2, 2021 to Apr 18, 202217
- Chief executive officerDaniel Malloy V. Feb 28, 2019 to May 19, 202218
- Chief executive officerJ. Robert Bredahl Jun 22, 2017 to Feb 28, 201919
- PresidentDavid E. Govrin Nov 2, 2022 to now20
- PresidentDaniel Malloy V. Mar 1, 2021 to Jun 17, 202121
- PresidentSid Sankaran Mar 2, 2021 to Apr 18, 202217
- PresidentJ. Robert Bredahl Dec 23, 2014 to Feb 28, 201922
- Chief financial officerJames J. McKinney Jun 5, 2024 to now23
- Chief financial officerStephen Yendall Nov 9, 2022 to Nov 19, 202424
- Chief financial officerDavid W. Junius Oct 4, 2021 to Oct 3, 202225
- Chief financial officerChristopher S. Coleman Dec 23, 2014 to Mar 13, 202026
- Chief financial officerJ. Robert Bredahl Aug 14, 2013 to Aug 14, 201327
- Chief operating officerPrashanth Gangu Mar 2, 2021 to Apr 18, 202228
- Chief operating officerDavid W. Junius Oct 2, 2020 to Apr 16, 202129
- Chief operating officerJ. Robert Bredahl Aug 14, 2013 to Feb 23, 201727
Board members and other officers (48)
- Global Head of P&CPatrick John Charles Apr 16, 2026 to now30
- Global Head of A&HThomas C. Leonardo Apr 16, 2026 to now31
- Group Chief Underwriting OffAnthony Shapella Jan 13, 2025 to now32
- Chief Accounting OfficerEvan Cabat Dec 16, 2024 to now33
- Chief Risk OfficerAndreas Kull Mar 10, 2022 to Jun 2, 202234
- EVPJanice Weidenborner Mar 1, 2021 to Mar 1, 202135
- Chief Risk Officer, Chief Act.Jeffrey W. Davis Mar 2, 2021 to Apr 16, 202136
- Pres., Int'l ReinsuranceManhem Monica Cramer Mar 2, 2021 to Jan 4, 202337
- Chief People OfficerVievette Henry Mar 2, 2021 to Apr 18, 202238
- Chief Accounting OfficerAnthony L. Lehan May 13, 2021 to Apr 16, 202439
- Pres., Third Point Re USA LtdDavid E. Govrin May 13, 2019 to Apr 18, 202240
- Chief Risk OfficerNicholas J. D. Campbell Jan 5, 2018 to Mar 1, 202141
- Chief Reserving ActuaryJustin J. Brenden Nov 13, 2018 to Dec 14, 202242
- Chief Accounting OfficerYan Leclerc Mar 7, 2017 to Mar 10, 202043
- Pres., Third Point Re USA Ltd.Thomas C. Wafer Mar 2, 2015 to Feb 23, 201744
- Chief Reserving ActuaryJonathan Norton Dec 12, 2014 to Mar 2, 201845
- EVP, UnderwritingAnthony Urban Aug 14, 2013 to Sep 15, 201646
- Chief Accounting OfficerChristopher S. Coleman Aug 14, 2013 to Mar 1, 202147
- EVP, UnderwritingDaniel Malloy V. Aug 14, 2013 to Mar 2, 201848
- SVP, UnderwritingManoj K. Gupta Aug 14, 2013 to Mar 5, 201949
- Chief Actuary & CROMichael McKnight Aug 14, 2013 to Aug 20, 201350
- EVP, Gen Counsel and SecretaryTonya L. Marshall Aug 14, 2013 to Mar 2, 201551
- Board memberSabra R. Purtill Apr 6, 2026 to now52
- Board memberMartin Peter Hudson Sep 9, 2025 to now53
- Board memberSusan Lee Cross May 28, 2024 to now54
- Board memberSaw Meng Tee Nov 7, 2024 to Nov 7, 202455
- Board memberBronislaw Edmund Masojada May 5, 2023 to now56
- Board memberJason Robart Mar 3, 2022 to now57
- Board memberScott Egan Sep 22, 2022 to now16
- Board memberFranklin Montross Iv. Mar 2, 2021 to now58
- Board memberRachelle Keller Mar 2, 2021 to Mar 2, 202159
- Board memberSharon M. Ludlow Mar 2, 2021 to now60
- Board memberWei Han Tan Mar 4, 2021 to Jun 26, 202361
- Board memberDaniel Malloy V. Mar 2, 2020 to Apr 16, 202162
- Board memberMedhi Mahmud Aug 7, 2020 to now63
- Board memberSid Sankaran Aug 8, 2019 to Apr 18, 202264
- Board memberJoseph L. Dowling Iii. Nov 5, 2019 to May 21, 202165
- Board memberGretchen A. Hayes May 9, 2018 to Nov 17, 202266
- Board memberJohn K. Kim Mar 10, 2014 to Mar 10, 201467
- Board memberGary Douglas Walters Jul 16, 2014 to May 5, 201668
- Board memberJoshua L. Targoff Aug 14, 2013 to Mar 4, 202069
- Board memberMary R. Hennessy Aug 14, 2013 to May 10, 201970
- Board memberSteve Elliott Fass Aug 14, 2013 to May 10, 201971
- Board memberWilliam Spiegel Aug 14, 2013 to Aug 14, 201372
- Board memberMark Parkin Nov 7, 2013 to May 21, 202173
- Board memberNeil McConachie Nov 7, 2013 to May 10, 201974
- General counselRachael J. Dugan Mar 2, 2021 to Apr 18, 202275
- General counselJanice Weidenborner Jan 8, 2016 to Mar 2, 202076
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- ALC Health (Hong Kong) LTD. Hong Kong4
- Akeso Care Management, Inc. Indiana4
- Alstead Reinsurance Ltd. Bermuda4
- Gate's Bay Services Limited United Kingdom4
- Global Response Limited United Kingdom4
- IMG CANADA INSURANCE SERVICES LTD. Canada4
- IMG Europe AB Sweden4
- IMG Europe Ltd. United Kingdom4
- International Medical Administrators, Inc. Nebraska4
- International Medical Group Holdings Limited United Kingdom4
- International Medical Group Limited United Kingdom4
- International Medical Group, Inc. Indiana4
- Oakwood Insurance Company Tennessee4
- S.I. Holdings (Luxembourg) S.á r.l Luxembourg4
- Sirius Acquisitions Holding Company Delaware4
- Sirius Global Services LLC Delaware4
- Sirius Group International S.á r.l Luxembourg4
- Sirius Insurance Holding Sweden AB Sweden4
- Sirius International Corporate Member Limited United Kingdom4
- Sirius International Managing Agency Limited United Kingdom4
- Sirius International UK Holdings II Ltd United Kingdom4
- Sirius Re Holdings, Inc. Delaware4
- SiriusPoint America Insurance Company New York4
- SiriusPoint Bermuda Insurance Company Ltd. Bermuda4
All 29 listed subsidiaries
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Third Point Reinsurance Ltd.May 14, 2013 to Feb 26, 20213
Timeline
- Jul 29, 20268-K Results of operations; Regulation FD disclosure77
- May 21, 20268-K Shareholder vote78
- May 7, 20268-K Results of operations; Regulation FD disclosure79
- Mar 30, 20268-K Change in control80
- Mar 23, 20268-K Executive or director change81
- Mar 16, 20268-K Executive or director change; Regulation FD disclosure82
- Feb 18, 20268-K Results of operations; Regulation FD disclosure83
- Feb 12, 20268-K Other events84
- Jan 30, 20268-K Other events85
- Jan 29, 20268-K Other events86
- Nov 3, 20258-K Other events87
- Oct 30, 20258-K Results of operations; Regulation FD disclosure; Other events88
- Mar 8, 2023New chief executive Robin Gibbs becomes CEO15
- Sep 22, 2022New chief executive Scott Egan becomes CEO16
- Mar 2, 2021New chief executive Sid Sankaran becomes CEO17
- Feb 28, 2019New chief executive Daniel Malloy V. becomes CEO18
- Jun 22, 2017New chief executive J. Robert Bredahl becomes CEO19
- Jun 10, 2011Founded SiriusPoint Ltd is founded2
Calendar
Coming up
- Oct 29, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.72 a share, on Oct 30, 2025.89
When it reported results
- Jul 29, 2026Reported quarterly or annual results77
- May 7, 2026Reported quarterly or annual results79
- Feb 18, 2026Reported quarterly or annual results83
- Oct 30, 2025Reported quarterly or annual results88
- Aug 4, 2025Reported quarterly or annual results90
- May 5, 2025Reported quarterly or annual results91
- Feb 18, 2025Reported quarterly or annual results92
- Oct 31, 2024Reported quarterly or annual results93
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
363 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 69 major events, 205 insider forms, 46 large holders, 23 other. The latest 20:
- Sep 2, 20264 EDGAR
- Aug 11, 2026SCHEDULE 13G EDGAR
- Jul 29, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jun 2, 20264 EDGAR
- May 29, 20264 EDGAR
- May 29, 20264 EDGAR
- May 29, 20264 EDGAR
- May 29, 20264 EDGAR
- May 29, 20264 EDGAR
- May 29, 20264 EDGAR
- May 29, 20264 EDGAR
- May 27, 2026S-8 EDGAR
- May 21, 20268-K EDGAR
- May 14, 2026SCHEDULE 13G/A EDGAR
- May 14, 2026SCHEDULE 13G EDGAR
- May 13, 20264 EDGAR
- May 7, 202610-Q EDGAR
- May 7, 20268-K EDGAR
- May 4, 20264 EDGAR
The 363 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
10 open-market trades by officers, directors and large owners since October 2021: 7 buys and 3 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 8, 2025 | de la Gueronniere RafeDirector | Sale | 30,000 | $19.55 | $586.5K | Form 4 |
| Feb 27, 2025 | Loeb Daniel SDirector | Sale | 4,106,631 | $13.71 | $56.3M | Form 4 |
| Aug 13, 2024 | Cabat EvanChief Accounting Officer | Sale | 2,000 | $14.43 | $28.9K | Form 4 |
| Jun 23, 2023 | TAN WEI HANDirector | Buy | 17,054 | $8.92 | $152.1K | Form 4 |
| Jun 5, 2023 | TAN WEI HANDirector | Buy | 1,542 | $9.00 | $13.9K | Form 4 |
| May 25, 2023 | Loeb Daniel SDirector | Buy | 105 | $23.75 | $2.5K | Form 4 |
| May 24, 2023 | Loeb Daniel SDirector | Buy | 728 | $23.74 | $17.3K | Form 4 |
| May 23, 2023 | Loeb Daniel SDirector | Buy | 28,463 | $23.68 | $674.0K | Form 4 |
| May 22, 2023 | Loeb Daniel SDirector | Buy | 5,500 | $23.29 | $128.1K | Form 4 |
| Nov 16, 2022 | Hayes Gretchen A.Director | Buy | 4,200 | $5.98 | $25.1K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- DONALD SMITH & CO., INC.SCHEDULE 13G, 7 filings Feb 14, 2025 to Aug 11, 202694
- Capital Research Global InvestorsSCHEDULE 13G/A, 7 filings Feb 11, 2022 to May 14, 202695
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 28, 202696
- VANGUARD GROUP INCSCHEDULE 13G/A, 6 filings Feb 10, 2022 to Mar 26, 202697
- Wellington Management CompanySCHEDULE 13G/A, 6 filings Feb 4, 2022 to Nov 12, 202598
- BlackRockSCHEDULE 13G/A, 8 filings Feb 3, 2022 to Apr 23, 202599
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G, 2 filings Feb 8, 2022 to Apr 15, 2025100
- CM BERMUDA LtdSCHEDULE 13D/A, 4 filings Nov 22, 2024 to Mar 3, 2025101
- Daniel S. LoebSCHEDULE 13D/A, 5 filings May 17, 2022 to Feb 28, 2025102
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Scott EganCEO and Director | 54 | $1.2M | $9.8M103 |
| 2025 | David E. GovrinGroup President & CEO of Global Reinsurance | 62 | $693.2K | $3.6M103 |
| 2025 | James J. McKinneyChief Financial Officer | 46 | $640.9K | $2.9M103 |
| 2025 | Thomas LeonardoGlobal Head of Accident and Health | 55 | $586.5K | $2.6M103 |
| 2025 | Rob GibbsPresident & CEO, SiriusPoint International | 51 | $537.0K | $1.5M103 |
| 2024 | Scott EganCEO and Director | 54 | $1.1M | $9.4M103 |
| 2024 | David E. GovrinGroup President & CEO of Global Reinsurance | 62 | $672.0K | $3.4M103 |
| 2024 | James J. McKinneyChief Financial Officer | 46 | $363.0K | $2.2M103 |
| 2024 | Rob GibbsPresident & CEO, SiriusPoint International | 51 | $485.5K | $1.8M103 |
| 2023 | Scott EganCEO and Director | 54 | $1.1M | $10.3M103 |
| 2023 | David E. GovrinGroup President & CEO of Global Reinsurance | 62 | $675.0K | $3.8M103 |
| 2023 | Rob GibbsPresident & CEO, SiriusPoint International | 51 | $477.5K | $2.3M103 |
SEC filer profile
How SiriusPoint Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSiriusPoint Ltd1
- CIK0001576018
- Employer ID (EIN)98-15993725
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
- Incorporated inBermuda5
- Fiscal year endsDecember 311
- Industry code (SIC)6331 Fire, Marine & Casualty Insurance1
- SEC reviewing officeOffice of Finance, Division of Corporation Finance1
- Business addressPoint Building, 3 Waterloo Lane, Pembroke, HM 08, Bermuda1
- Mailing addressPoint Building, 3 Waterloo Lane, Pembroke, Bermuda1
- Phone1 441 542 33001
- Shares outstanding116,165,016 as of Jul 24, 202613
- Public float$2.1B as of Jun 30, 20255
- AuditorPricewaterhouseCoopers LLP, New York, New York PCAOB ID 238; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceMay 14, 20131
- Filings874 in all: 4 (389), 8-K (156), 3 (68), 10-Q (39), SC 13G/A (32), 10-K (13), 425 (13), DEF 14A (13)1
All 46 form types
SC 13G (12), CORRESP (11), SCHEDULE 13G (11), SCHEDULE 13G/A (11), UPLOAD (11), DEFA14A (9), 424B5 (8), FWP (8), 5 (6), SC 13D/A (6), 8-K/A (5), ARS (4), S-1/A (4), S-3ASR (4), 4/A (3), 424B7 (3), S-8 (3), SCHEDULE 13D/A (3), 144 (2), 424B3 (2), 8-A12B (2), DRS/A (2), DRSLTR (2), EFFECT (2), PRE 14A (2), S-4/A (2), SC 13D (2), 25-NSE (1), 3/A (1), 424B1 (1), 424B4 (1), CERT (1), CERTNYS (1), CT ORDER (1), DRS (1), S-1 (1), S-4 (1), S-8 POS (1)
- Latest filingsAnnual report (10-K) Feb 24, 2026
Quarterly report (10-Q) Jul 29, 2026
Proxy statement (DEF 14A) Apr 10, 2026
Latest 8-K (8-K) Jul 29, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Shares, $0.10 par value | SPNT | New York Stock Exchange |
| 8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $25.00 liquidation preference per share | SPNT PB | New York Stock Exchange |
From the cover page of the 10-K filed Feb 24, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks SiriusPoint Ltd names in Item 1A of its 10-K filed Feb 24, 2026: 62 risks under these headings, as written.5
- Risks Relating to Our Business
- Our results of operations fluctuate from period to period and may not be indicative of our long-term prospects.
- We may be adversely impacted by inflation and the changing tariff landscape.
- Operational, cybersecurity, technology-related, and artificial intelligence (“AI”) risks, including system failures, data breaches, ransomware attacks, supply chain compromises of third party service providers, failures or harmful outputs of AI models, or other business interruption events — including those resulting from malicious cyber-attacks on us or our business partners or service providers — could disrupt or otherwise negatively impact our business.
- Competitors with greater resources may make it difficult for us to effectively market our products.
- Consolidation in the insurance and reinsurance industry could adversely impact us.
- If actual renewals of our existing contracts do not meet expectations, our premiums written in future years and our future results of operations could be materially adversely affected.
- We may experience issues with outsourcing and third-party relationships which may impact our ability to conduct business in a prudent manner and could negatively impact our operations, results, and financial condition.
- Given the inherent uncertainty of models and software, their usefulness as a tool to evaluate risk is subject to a high degree of uncertainty that could result in actual losses that are materially different than our estimates including Probable Maximum Losses (PMLs), and our financial results may be adversely impacted, perhaps significantly.
- Our claims and claim expense reserves are subject to inherent uncertainties, which could cause our losses to exceed our loss reserves.
- We are exposed to unpredictable catastrophic events that have adversely affected, and may in the future affect our results of operations and financial condition.
- We have exposure to potential terrorist acts that can materially and adversely affect our business, results of operations and/or financial condition.
The other 51 risks
- Global climate change may have a material adverse effect on our business, operating results and financial condition.
- We are exposed to unpredictable casualty insurance risks that could adversely affect our results of operations and financial condition.
- The property and casualty insurance and reinsurance industry is highly cyclical, and we expect to continue to experience periods characterized by excess underwriting capacity and unfavorable premium rates.
- The effect of emerging claim and coverage issues on our business is uncertain and as a result, we may suffer losses from unfavorable outcomes from litigation and other legal proceedings.
- Recent or future U.S. federal or state legislation may impact the private catastrophe risk markets and reduce the demand for our property insurance and reinsurance products.
- We are reliant on financial strength and credit ratings, and any downgrade, withdrawal of ratings, or change in outlook may have a material adverse effect on our business, prospects, financial condition and results from operations.
- We have significant foreign operations that expose us to certain additional risks, including foreign currency risks and legal, political and operational risks.
- If we do not successfully manage transitions associated with key management changes, our business, reputation and ratings could be adversely affected.
- We are dependent on key executives, the loss of whom could adversely affect our business.
- Our inability to provide collateral to certain counterparties on commercially acceptable terms as we grow could significantly and negatively affect our ability to implement our business strategy.
- Our ability to pay dividends may be constrained by our holding company structure and certain regulatory and other factors.
- Inability to service our indebtedness could adversely affect our liquidity and financial condition and could potentially result in a downgrade or withdrawal of our credit ratings, any of which could adversely affect our financial condition and results of operations.
- Our indebtedness may limit cash flow available to invest in the ongoing needs of our business and may otherwise place us at a competitive disadvantage compared to our competitors.
- We may not have the liquidity or ability to raise the funds necessary to pay the principal or interest on our outstanding debt obligations.
- We may need additional capital in the future in order to operate our business, and such capital may not be available to us or may not be available to us on acceptable terms. Furthermore, additional capital raising could dilute your ownership interest in the Company and may cause the value of your shares to decline.
- We depend on our clients’ evaluations of the risks associated with their insurance underwriting, which may subject us to reinsurance losses.
- The involvement of reinsurance brokers and MGAs subjects us to their credit risk, and the inability to obtain business provided from brokers could adversely affect our business strategy and results of operations.
- We may be unable to purchase the retrocessional coverage we need, or we may be unable to collect on such coverage, either of which could adversely affect our business, financial condition, and results of operations.
- We face risks arising from strategic transactions, such as acquisitions, dispositions, investments, mergers, joint ventures, or entry into new lines of business. These transactions can be significant and may negatively affect our reputation, business, financial condition, or results of operations.
- If we fail to maintain an effective system of internal controls over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.
- We may incur losses as we execute on our strategy to develop our relationships with MGAs.
- We face risks associated with delegating authority to third party MGAs to secure insurance and reinsurance policies on our behalf. If we fail to adequately oversee and manage these MGAs, we could experience unintended concentrations of risk or result significant underwriting losses, adversely affecting our business, financial condition, and operating results.
- Damage to our reputation could have a material adverse effect on our business, financial condition, and operating results.
- Increasing scrutiny and evolving expectations regarding our environmental, social, and governance (“ESG”) practices may impose additional costs on us or expose us to new or heightened risks.
- Risks Relating to Our Investment Strategy
- Conflicts of interest among Third Point LLC and its principals and SiriusPoint may adversely affect us; potential conflicts of interest may also arise or exist due to the compensation arrangements and other aspects of our investment arrangements with Third Point LLC and its affiliates.
- The SiriusPoint investment portfolio may suffer reduced returns or losses, which could adversely affect our results of operations and financial condition. Adverse changes in interest rates, foreign currency exchange rates, equity markets,
- debt markets or market volatility, as well as idiosyncratic risks of concentrated positions could result in significant losses to the fair value of our investment portfolio.
- We face risks associated with joint ventures and investments in which we share ownership or management with third parties.
- Risks Relating to Insurance and Other Regulations
- The regulatory framework under which SiriusPoint operates and potential changes thereto could have a material adverse effect on its business.
- We face risks related to changes in Bermuda law and regulations, and the political environment in Bermuda.
- We are subject to the risk of becoming an investment company under U.S. federal securities law.
- Changes in U.S. healthcare legislation could negatively affect our accident and health business.
- Our operating subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.
- Bermuda insurance laws regarding the change of control of insurance companies may limit the acquisition of our shares and the voting rights of certain shareholders.
- Risks Relating to Taxation
- We have significant deferred tax assets, which may become devalued if either SiriusPoint does not generate sufficient future taxable income or applicable corporate tax rates are reduced (or applicable tax laws otherwise change).
- Certain of our non-U.S. entities may become subject to United States federal income taxation.
- Certain of our intra-group transactions could become subject to the U.S. Base Erosion and Anti-Abuse Minimum Tax (“BEAT”), which could have a material adverse impact on operating results and make it difficult to forecast our effective tax rate.
- Intra-group distributions and other payments of cash or other assets could become subject to incremental income or withholding taxes.
- If we were treated as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes, our U.S. shareholders would be subject to adverse tax consequences.
- If we were treated as a controlled foreign corporation (“CFC”) with respect to a U.S. shareholder or we were subject to the rules for related person insurance income (“RPII”), certain U.S. shareholders (including tax-exempts) could become subject to adverse tax consequences.
- New tax laws and regulations, along with changes in existing tax laws and regulations, are continuously being proposed and enacted, which may affect our financial condition and results of operations; more specifically, Bermuda and other countries in which we operate have enacted new tax laws that may result higher taxation of the Company.
- Risks Relating to Our Common Shares
- Future sales of shares by existing shareholders could cause our share price to decline, even if our business is performing well.
- Limited or changing analysts coverage could adversely affect our share price.
- If the ownership of our common shares continues to be concentrated, it could prevent shareholders from influencing significant corporate decisions.
- We do not intend to pay dividends on our common shares and, consequently, shareholders’ ability to achieve a return on their investment will depend on appreciation in the price of our common shares.
- We may repurchase our common shares without our shareholders’ consent.
- Holders of our shares may have difficulty effecting service of process on us or enforcing judgments against us in the U.S.
- U.S. persons who own our shares may have more difficulty in protecting their interests than U.S. persons who are shareholders of a U.S. corporation.
- Provisions in our Bye-Laws may reduce or increase the voting rights of our shares.
- Our Bye-Laws contain provisions that could discourage takeovers and business combinations that our shareholders might consider in their best interests.
- The market price of our common shares may fluctuate significantly.
Legal proceedings
The Company and its subsidiaries are subject to lawsuits and regulatory actions in the normal course of business that do not arise from or directly relate to claims on reinsurance treaties or contracts or direct surplus lines insurance policies. In the Company’s industry, business litigation may involve allegations of underwriting or claims-handling errors or misconduct, disputes relating to the scope of, or compliance with, the terms of delegated underwriting agreements, employment claims, regulatory actions or disputes arising from the Company’s business ventures. The Company’s operating subsidiaries are subject to claims litigation involving, among other things, disputed interpretations of policy coverages. Generally, the Company’s direct insurance operations are subject to greater frequency and diversity of claims and claims-related litigation than its reinsurance operations and, in some jurisdictions, may be subject to direct actions by allegedly injured persons or entities seeking damages from policyholders. These lawsuits, which involve or arise out of claims on policies issued by the Company’s subsidiaries, are typical to the insurance industry in general and in the normal course of our business. These claims are considered in the Company’s loss and loss expense reserves. In addition, the Company may from time to time engage in litigation or arbitration related to its claims for payment in respect of ceded reinsurance, including disputes that challenge the Company’s ability to enforce its underwriting intent. Such matters could result, directly or indirectly, in providers of protection not meeting their obligations to the Company or not doing so on a timely basis. The Company may also be subject to other disputes from time to time, relating to operational or other matters distinct from insurance or reinsurance claims.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSiriusPoint Ltd filings on SEC EDGAR
- 2
- 3SEC EDGARSiriusPoint Ltd filings on SEC EDGAR
- 4
- 5
- 6SEC EDGARSiriusPoint Ltd 10-K for fiscal 2025
- 7SEC EDGARSiriusPoint Ltd 10-K for fiscal 2019
- 8SEC EDGARSiriusPoint Ltd 10-K for fiscal 2020
- 9SEC EDGARSiriusPoint Ltd 10-K for fiscal 2021
- 10SEC EDGARSiriusPoint Ltd 10-K for fiscal 2022
- 11SEC EDGARSiriusPoint Ltd 10-Q for fiscal 2025
- 12SEC EDGARSiriusPoint Ltd 10-Q for fiscal 2026
- 13SEC EDGARSiriusPoint Ltd 10-Q for fiscal 2026
- 14SEC EDGARSiriusPoint Ltd 10-K for fiscal 2019
- 15SEC EDGARRobin Gibbs, Chief executive officer
- 16SEC EDGARScott Egan, Chief executive officer
- 17
- 18
- 19
- 20SEC EDGARDavid E. Govrin, President
- 21SEC EDGARDaniel Malloy V., President
- 22SEC EDGARJ. Robert Bredahl, President
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33SEC EDGAREvan Cabat, Chief Accounting Officer
- 34SEC EDGARAndreas Kull, Chief Risk Officer
- 35SEC EDGARJanice Weidenborner, EVP
- 36
- 37
- 38SEC EDGARVievette Henry, Chief People Officer
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46SEC EDGARAnthony Urban, EVP, Underwriting
- 47
- 48SEC EDGARDaniel Malloy V., EVP, Underwriting
- 49SEC EDGARManoj K. Gupta, SVP, Underwriting
- 50
- 51
- 52SEC EDGARSabra R. Purtill, Board member
- 53SEC EDGARMartin Peter Hudson, Board member
- 54SEC EDGARSusan Lee Cross, Board member
- 55SEC EDGARSaw Meng Tee, Board member
- 56
- 57SEC EDGARJason Robart, Board member
- 58SEC EDGARFranklin Montross Iv., Board member
- 59SEC EDGARRachelle Keller, Board member
- 60SEC EDGARSharon M. Ludlow, Board member
- 61SEC EDGARWei Han Tan, Board member
- 62SEC EDGARDaniel Malloy V., Board member
- 63SEC EDGARMedhi Mahmud, Board member
- 64SEC EDGARSid Sankaran, Board member
- 65SEC EDGARJoseph L. Dowling Iii., Board member
- 66SEC EDGARGretchen A. Hayes, Board member
- 67SEC EDGARJohn K. Kim, Board member
- 68SEC EDGARGary Douglas Walters, Board member
- 69SEC EDGARJoshua L. Targoff, Board member
- 70SEC EDGARMary R. Hennessy, Board member
- 71SEC EDGARSteve Elliott Fass, Board member
- 72SEC EDGARWilliam Spiegel, Board member
- 73SEC EDGARMark Parkin, Board member
- 74SEC EDGARNeil McConachie, Board member
- 75SEC EDGARRachael J. Dugan, General counsel
- 76SEC EDGARJanice Weidenborner, General counsel
- 77
- 78SEC EDGARShareholder vote
- 79
- 80SEC EDGARChange in control
- 81SEC EDGARExecutive or director change
- 82
- 83
- 84SEC EDGAROther events
- 85SEC EDGAROther events
- 86SEC EDGAROther events
- 87SEC EDGAROther events
- 88
- 89NasdaqNasdaq calendar
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103